bioecon Member area
Suppliers · Producer · Genome & Epigenome Editing (agricultural/industrial applications only — human-therapeutics CRISPR platforms excluded by scope decision)

Shandong Shunfeng Biotechnology

active ChinaAsia Founded 2018 checked 2026-10-05

Profile

Shandong Shunfeng Biotechnology Co., Ltd. (Shunfeng Bio) is a privately held Chinese plant biotechnology company developing gene-editing tools and precision crop breeding; founded in 2018 and headquartered in Jinan, Shandong. Its core technology is patented CRISPR gene-editing enzymes Cas-SF01 and Cas-SF02 (a “gene scissor” platform validated in 70+ labs). Key products include high-oleic (high-oleic-acid) soybean with China’s first regulator-approved plant gene-edited safety certificate (oil-oleic 80%+, up to 85%), plus gene-edited pipelines such as dwarf corn (security certificate in 2024) and other crops. In 2025–2026 it remains active: it signed a 2025-09-10 worldwide licensing agreement with KWS for global, all-crop gene-editing applications, and 2026 news reports continued scaling (e.g., 2026 planned multi-region planting) and ongoing approvals. Reported shareholders include Jinan Henghe Bio (52.7506%) and Jinan High-tech Finance (17.5835%); no stock listing/IPO was found. Funding: 2021 and 2023/2022 rounds are mentioned in profiles but amounts/valuation are inconsistent; one source cites RMB 120m in 2021. Scale details (revenue/capacity/employees) were not provided in the search results. Partners/customers mentioned include KWS, INARI, GDM, Performance Plants, and Origin Agritech (via Cas-SF01 licensing).

Sources#

Industry
Seeds & genetics
Topics
GM traits & gene editing
Role
Producer — “…is a privately held Chinese plant biotechnology company developing gene-editing tools and precision crop breed…”

Bio-solutions it supplies 0

Not yet cited as a supplier in a graded solution.

What they offer

This company does not publish its products or services — we find out through an introduction.

News & status 6

Network: owners, partners, peers

Partners & deals 1

licensingKWS
…n 2024) and other crops. In 2025–2026 it remains active: it signed a 2025-09-10 worldwide licensing agreement with KWS for global, all-crop gene-editing applications, and 2026 news reports continued…

Similar companies

北京大北农生物技术有限公司 · Shriram Bioseed Genetics (A Division of DCM Shriram Ltd) · Soy-Sky FarmTech Company Limited · 正邦集团 · JK Agri Genetics Limited · Mahyco · CHAROEN POKPHAND SEEDS (INDIA) PRIVATE LIMITED · KingAgroot CropScience 清原作物科学

Identity & contacts

Contacts, people and legal identity are available to members.

Sign in as a member